Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings
- PMID: 12453678
- DOI: 10.1016/s0169-409x(02)00160-6
Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings
Abstract
Receptor for Advanced Glycation Endproducts (RAGE) is a member of the immunoglobulin superfamily of cell surface molecules capable of interacting with a broad spectrum of ligands, including advanced glycation endproducts (AGEs), amyloid fibrils, S100/calgranulins and amphoterin. The biology of RAGE is dictated by the accumulation of these ligands at pathologic sites, leading to upregulation of the receptor and sustained RAGE-dependent cell activation eventuating in cellular dysfunction. Although RAGE is not central to the initial pathogenesis of disorders in which it ultimately appears to be involved, such as diabetes, amyloidoses, inflammatory conditions and tumors (each of these conditions leading to accumulation of RAGE ligands), the receptor functions as a progression factor driving cellular dysfunction and exaggerating the host response towards tissue destruction, rather than restitution of homeostasis. These observations suggest that RAGE might represent a therapeutic target in a diverse group of seemingly unrelated disorders linked only by a multiligand receptor with an unusually wide and diverse repertoire of ligands, namely, RAGE.
Copyright 2002 Elsevier Science B.V.
Similar articles
-
Receptor for advanced glycation endproducts (RAGE) and the complications of diabetes.Ageing Res Rev. 2002 Feb;1(1):1-15. doi: 10.1016/s0047-6374(01)00366-9. Ageing Res Rev. 2002. PMID: 12039445 Review.
-
The biology of the receptor for advanced glycation end products and its ligands.Biochim Biophys Acta. 2000 Dec 20;1498(2-3):99-111. doi: 10.1016/s0167-4889(00)00087-2. Biochim Biophys Acta. 2000. PMID: 11108954 Review.
-
RAGE: a multiligand receptor contributing to the cellular response in diabetic vasculopathy and inflammation.Semin Thromb Hemost. 2000;26(5):485-93. doi: 10.1055/s-2000-13204. Semin Thromb Hemost. 2000. PMID: 11129404 Review.
-
RAGE: a multi-ligand receptor unveiling novel insights in health and disease.Curr Med Chem. 2010;17(21):2232-52. doi: 10.2174/092986710791331086. Curr Med Chem. 2010. PMID: 20459381 Review.
-
Receptor for age (RAGE) is a gene within the major histocompatibility class III region: implications for host response mechanisms in homeostasis and chronic disease.Front Biosci. 2001 Oct 1;6:D1151-60. doi: 10.2741/schmidt. Front Biosci. 2001. PMID: 11578972 Review.
Cited by
-
Role of Advanced Glycation End Products in Intervertebral Disc Degeneration: Mechanism and Therapeutic Potential.Oxid Med Cell Longev. 2022 Dec 17;2022:7299005. doi: 10.1155/2022/7299005. eCollection 2022. Oxid Med Cell Longev. 2022. PMID: 36573114 Free PMC article. Review.
-
Polymorphisms in the receptor for advanced glycation end-products (RAGE) gene and circulating RAGE levels as a susceptibility factor for non-alcoholic steatohepatitis (NASH).PLoS One. 2018 Jun 21;13(6):e0199294. doi: 10.1371/journal.pone.0199294. eCollection 2018. PLoS One. 2018. PMID: 29928018 Free PMC article.
-
Diagnostic hallmarks and pitfalls in late-onset progressive transthyretin-related amyloid-neuropathy.J Neurol. 2013 Dec;260(12):3093-108. doi: 10.1007/s00415-013-7124-7. Epub 2013 Oct 8. J Neurol. 2013. PMID: 24101130
-
The Research on the Relationship of RAGE, LRP-1, and Aβ Accumulation in the Hippocampus, Prefrontal Lobe, and Amygdala of STZ-Induced Diabetic Rats.J Mol Neurosci. 2017 May;62(1):1-10. doi: 10.1007/s12031-017-0892-2. Epub 2017 Apr 11. J Mol Neurosci. 2017. PMID: 28401370
-
Rehmannia glutinosa suppresses inflammatory responses elicited by advanced glycation end products.Inflammation. 2012 Aug;35(4):1232-41. doi: 10.1007/s10753-012-9433-x. Inflammation. 2012. PMID: 22327862
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
